Stock TAIPY TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Taisho Pharmaceutical Holdings Co., Ltd.

Equities

TAIPY

US87402P1057

Delayed OTC Markets
Other stock markets
 01:06:47 17/05/2024 am IST 		5-day change 1st Jan Change
12 USD 0.00% Intraday chart for Taisho Pharmaceutical Holdings Co., Ltd. 0.00% -18.97%
13/05 Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank... Our Logo

Strengths

  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.

Weaknesses

  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Investor Rating
-
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-

Consensus

Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. TAIPY Stock
  4. Ratings Taisho Pharmaceutical Holdings Co., Ltd.